About this trial
According to the WHO report of 2021, approximately 10 million new cases were reported in 2020, of which 1 million occurred in the pediatric population. However, epidemiological data available on tuberculosis (TB) in pediatric age are extremely limited due to diagnostic challenges in this patient category. Furthermore, children are almost never included in national surveillance systems due to the lack of connections between individual pediatricians, pediatric hospitals, and national surveillance programs. It is therefore reasonable to assume that the disease may be significantly underestimated both in Italy and worldwide.
Eligibility criteria
Qualifiers
Pediatric patients (0-18 years old) at the time of the initial observation
Patients affected by active and latent TB, as defined by the criteria of the World Health Organization
Patients exposed to TB who are found to be non-infected at the end of the window period
Informed consent signed by parents/legal guardian or by the patient who has reached the legal age of consent, assent of the minor
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed